Literature DB >> 26392315

Hepatitis B virus X promotes hepatocellular carcinoma development via nuclear protein 1 pathway.

Yesol Bak1, Hye-jun Shin1, In seon Bak1, Do-young Yoon2, Dae-Yeul Yu3.   

Abstract

Hepatocellular carcinoma (HCC) is one of the most common malignancies and chronic hepatitis B virus (HBV) infection is a major risk factor for HCC. Hepatitis B virus X (HBx) protein relates to trigger oncogenesis. HBx has oncogenic properties with a hyperproliferative response to HCC. Nuclear protein 1 (NUPR1) is a stress-response protein, frequently upregulated in several cancers. Recent data revealed that NUPR1 is involved in tumor progression, but its function in HCC is not revealed yet. Here we report HBx can induce NUPR1 in patients, mice, and HCC cell lines. In an HBx transgenic mouse model, we found that HBx overexpression upregulates NUPR1 expression consistently with tumor progression. Further, in cultured HBV positive cells, HBx knockdown induces downregulation of NUPR1. Smad4 is a representative transcription factor, regulated by HBx, and we showed that HBx upregulates NUPR1 by Smad4 dependent way. We found that NUPR1 can inhibit cell death and induce vasculogenic mimicry in HCC cell lines. Moreover, NUPR1 silencing in HepG2-HBx showed reduced cell motility. These results suggest that HBx can modulate NUPR1 expression through the Smad4 pathway and NUPR1 has a role in hepatocellular carcinoma progression.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell proliferation; Hepatitis B virus X; Hepatocellular carcinoma; Migration; NUPR1; Vasculogenic mimicry

Mesh:

Substances:

Year:  2015        PMID: 26392315     DOI: 10.1016/j.bbrc.2015.09.082

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Knockdown of NUPR1 inhibits the proliferation of glioblastoma cells via ERK1/2, p38 MAPK and caspase-3.

Authors:  Jun Li; Siyang Ren; Yongjian Liu; Zhigang Lian; Bin Dong; Yiqun Yao; Yinghui Xu
Journal:  J Neurooncol       Date:  2016-12-20       Impact factor: 4.130

2.  Spatiotemporal modulation of SMAD4 by HBx is required for cellular proliferation in hepatitis B-related liver cancer.

Authors:  Wang Chaomin; Niu Wenhao; Hua Jialei; Zhao Ting; Feng Honglei; Hao Zhuang; Wang Yichao; Bai Changsen; Li Yueguo
Journal:  Cell Oncol (Dordr)       Date:  2022-06-18       Impact factor: 7.051

3.  Identification of anti-SF3B1 autoantibody as a diagnostic marker in patients with hepatocellular carcinoma.

Authors:  Hai-Min Hwang; Chang-Kyu Heo; Hye Jung Lee; Sang-Seob Kwak; Won-Hee Lim; Jong-Shin Yoo; Dae-Yuel Yu; Kook Jin Lim; Jeong-Yoon Kim; Eun-Wie Cho
Journal:  J Transl Med       Date:  2018-06-28       Impact factor: 5.531

4.  Induction of nuclear protein-1 by thyroid hormone enhances platelet-derived growth factor A mediated angiogenesis in liver cancer.

Authors:  Ching-Ying Chen; Sheng-Ming Wu; Yang-Hsiang Lin; Hsiang-Cheng Chi; Syuan-Ling Lin; Chau-Ting Yeh; Wen-Yu Chuang; Kwang-Huei Lin
Journal:  Theranostics       Date:  2019-04-13       Impact factor: 11.556

5.  Serum anti-EIF3A autoantibody as a potential diagnostic marker for hepatocellular carcinoma.

Authors:  Chang-Kyu Heo; Hai-Min Hwang; Hye-Jung Lee; Sang-Seob Kwak; Jong-Shin Yoo; Dae-Yeul Yu; Kook-Jin Lim; Soojin Lee; Eun-Wie Cho
Journal:  Sci Rep       Date:  2019-07-30       Impact factor: 4.379

6.  NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance.

Authors:  M R Emma; J L Iovanna; D Bachvarov; R Puleio; G R Loria; G Augello; S Candido; M Libra; A Gulino; V Cancila; J A McCubrey; G Montalto; M Cervello
Journal:  Cell Death Dis       Date:  2016-06-23       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.